208 related articles for article (PubMed ID: 1956401)
1. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
Roche PA; Marks MS; Cresswell P
Nature; 1991 Dec; 354(6352):392-4. PubMed ID: 1956401
[TBL] [Abstract][Full Text] [Related]
2. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
4. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.
Roche PA; Cresswell P
Nature; 1990 Jun; 345(6276):615-8. PubMed ID: 2190094
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
6. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
7. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
8. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Ghosh P; Amaya M; Mellins E; Wiley DC
Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
[TBL] [Abstract][Full Text] [Related]
9. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
10. Intracellular transport and peptide binding properties of HLA class II glycoproteins.
Cresswell P; Avva RR; Davis JE; Lamb CA; Riberdy JM; Roche PA
Semin Immunol; 1990 Jul; 2(4):273-80. PubMed ID: 2104276
[TBL] [Abstract][Full Text] [Related]
11. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
Swier K; Miller J
J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
[TBL] [Abstract][Full Text] [Related]
12. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
13. Abnormal association between invariant chain and HLA class II alpha and beta chains in chronic lymphocytic leukemia.
Veenstra H; Jacobs P; Dowdle EB
Cell Immunol; 1996 Jul; 171(1):68-73. PubMed ID: 8660839
[TBL] [Abstract][Full Text] [Related]
14. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
Riberdy JM; Newcomb JR; Surman MJ; Barbosa JA; Cresswell P
Nature; 1992 Dec; 360(6403):474-7. PubMed ID: 1448172
[TBL] [Abstract][Full Text] [Related]
16. Early events in the assembly of major histocompatibility complex class II heterotrimers from their free subunits.
Nijenhuis M; Neefjes J
Eur J Immunol; 1994 Jan; 24(1):247-56. PubMed ID: 8020564
[TBL] [Abstract][Full Text] [Related]
17. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
18. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
19. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
20. Intracellular transport of invariant chain-MHC class II complexes to the peptide-loading compartment.
Xu X; Song W; Cho H; Qiu Y; Pierce SK
J Immunol; 1995 Sep; 155(6):2984-92. PubMed ID: 7673716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
